High MUC2 immunohistochemical expression is a predictor of poor response to preoperative radiochemotherapy (RCT) in rectal adenocarcinoma. [electronic resource]
- Applied immunohistochemistry & molecular morphology : AIMM May 2008
- 227-31 p. digital
Publication Type: Journal Article
1533-4058
10.1097/PAI.0b013e3181545944 doi
Adenocarcinoma--diagnosis Biomarkers, Tumor Biopsy Combined Modality Therapy Drug Therapy Female Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Intestinal Mucosa--drug effects Male Mucin-2--biosynthesis Neoplasm Metastasis Preoperative Care Prognosis Rectal Neoplasms--diagnosis